ASC Stock Analysis: Ardmore Shpng | NYSE
Marine Shipping | NYSE, USA | Market Cap: 790m USD | 12M Return: 80.4% | MHY0207T1001 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.7M
EPS Trend: -69.0%
Qual. Beats: 2
Rev. Trend: -75.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ardmore Shipping Corporation (NYSE: ASC) is a Bermuda-based shipping company that operates a fleet of 26 vessels engaged in the global seaborne transportation of petroleum products and chemicals. The fleet is composed primarily of 25 owned Eco-design vessels, with one additional chartered-in vessel. The company serves a diversified customer base that includes oil majors, national oil companies, oil and chemical traders, chemical companies, and pooling service providers. Founded in 2010 and headquartered in Hamilton, Bermuda, Ardmore Shipping completed its IPO in August 2013.
Operating within the GICS Energy sector under the Oil & Gas Storage & Transportation sub-industry, Ardmore participates in both the product tanker segment (carrying refined petroleum products such as gasoline, diesel, and jet fuel) and the chemical tanker segment (carrying specialty chemicals that require stainless steel tanks or specialized coatings). The companys focus on Eco-design vessels reflects the industrys shift toward more fuel-efficient and environmentally compliant tankers, which became the standard for newbuilds following regulatory phase-outs of single-hull tankers.
- TCE rates weaken as product tanker supply growth outpaces demand
- Eco-design fleet earns premium charter rates amid tightening environmental regulations
- Chemical tanker demand softens due to global manufacturing slowdown
- Fuel cost spread compresses profitability as bunker prices fluctuate
| Net Income: 109.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -10.10 > 1.0 |
| NWC/Revenue: 27.53% < 20% (prev 27.51%; Δ 0.02% < -1%) |
| CFO/TA 0.17 > 3% & CFO 127.2m > Net Income 109.3m |
| Net Debt (-11.6m) to EBITDA (146.6m): -0.08 < 3 |
| Current Ratio: 5.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.0m) vs 12m ago 0.68% < -2% |
| Gross Margin: 37.86% > 18% (prev 30.23%; Δ 7.63% > 0.5%) |
| Asset Turnover: 50.40% > 50% (prev 46.06%; Δ 4.34% > 0%) |
| Interest Coverage Ratio: 13.14 > 6 (EBIT TTM 104.6m / Interest Expense TTM 7.96m) |
| A: 0.13 (Total Current Assets 124.2m - Total Current Liabilities 22.8m) / Total Assets 757.6m |
| B: 0.33 (Retained Earnings 253.3m / Total Assets 757.6m) |
| C: 0.14 (EBIT TTM 104.6m / Avg Total Assets 730.7m) |
| D: 12.17 (Book Value of Equity 700.0m / Total Liabilities 57.5m) |
| Altman-Z'' = 15.70 = AAA |
| DSRI: 0.92 (Receivables 55.0m/52.8m, Revenue 368.3m/324.2m) |
| GMI: 0.80 (GM 30.23% / 37.86%) |
| AQI: 0.89 (AQ_t 0.04 / AQ_t-1 0.05) |
| SGI: 1.14 (Revenue 368.3m / 324.2m) |
| TATA: -0.02 (NI 109.3m - CFO 127.2m) / TA 757.6m) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of October 28, 2026, the stock is trading at USD 20.42 with a total of 766,078 shares traded. Over the past week, the price has changed by +8.21%, over one month by +12.51%, over three months by +30.42% and over the past year by +80.44%.
Current recommended Stop Loss: 19.30 (which is 5.5% or 1.4 ATR below the current price).
Ardmore Shpng has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy ASC.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 22.5 | 10.2% |
P/E Trailing = 7.6443
P/E Forward = 3.3852
P/S = 2.1453
P/B = 1.0277
P/EG = -6.04
Revenue TTM = 368.3m USD
EBIT TTM = 104.6m USD
EBITDA TTM = 146.6m USD
Long Term Debt = 33.4m USD (from longTermDebt, last quarter)
Short Term Debt = 502k USD (from shortTermDebt, last quarter)
Debt = 36.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 1.60m
Net Debt = -11.6m USD (calculated: Debt 36.6m - CCE 48.1m)
Enterprise Value = 778.5m USD (790.1m + Debt 36.6m - CCE 48.1m)
Interest Coverage Ratio = 13.14 (Ebit TTM 104.6m / Interest Expense TTM 7.96m)
EV/FCF = 58.02x (Enterprise Value 778.5m / FCF TTM 13.4m)
FCF Yield = 1.72% (FCF TTM 13.4m / Enterprise Value 778.5m)
FCF Margin = 3.64% (FCF TTM 13.4m / Revenue TTM 368.3m)
Net Margin = 29.67% (Net Income TTM 109.3m / Revenue TTM 368.3m)
Gross Margin = 37.86% ((Revenue TTM 368.3m - Cost of Revenue TTM 228.9m) / Revenue TTM)
Gross Margin QoQ = 47.80% (prev 36.40%)
Tobins Q-Ratio = 1.03 (Enterprise Value 778.5m / Total Assets 757.6m)
Interest Expense / Debt = 21.77% (Interest Expense 7.96m / Debt 36.6m)
Taxrate = 0.22% (241k / 109.5m)
NOPAT = 104.4m (EBIT 104.6m * (1 - 0.22%))
Current Ratio = 5.45 (Total Current Assets 124.2m / Total Current Liabilities 22.8m)
Debt / Equity = 0.05 (Debt 36.6m / totalStockholderEquity, last quarter 700.0m)
Debt / EBITDA = -0.08 (Net Debt -11.6m / EBITDA 146.6m)
Debt / FCF = -0.86 (Net Debt -11.6m / FCF TTM 13.4m)
Total Stockholder Equity = 661.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.95% (Net Income 109.3m / Total Assets 757.6m)
RoE = 16.52% (Net Income TTM 109.3m / Total Stockholder Equity 661.3m)
RoCE = 15.06% (EBIT 104.6m / Capital Employed (Equity 661.3m + L.T.Debt 33.4m))
RoIC = 14.57% (NOPAT 104.4m / Invested Capital 716.9m)
WACC = 5.85% (E(790.1m)/V(826.7m) * Re(5.11%) + D(36.6m)/V(826.7m) * Rd(21.77%) * (1-Tc(0.00)))
Discount Rate = 5.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -75.83 | Cagr: -1.02%
[DCF] Terminal Value 73.10% ; FCFF base≈41.5m ; Y1≈36.4m ; Y5≈29.4m
[DCF] Fair Price = 11.83 (EV 471.7m - Net Debt -11.6m = Equity 483.3m / Shares 40.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -69.01 | EPS CAGR: -31.19% | SUE: 3.05 | # QB: 2
Revenue Correlation: -75.37 | Revenue CAGR: -9.74% | SUE: 0.71 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.62 | Chg30d=+0.00% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=3.63 | Chg30d=+24.96% | Revisions=-25% | GrowthEPS=+282.1% | GrowthRev=+51.2%
EPS next Year (2027-12-31): EPS=2.84 | Chg30d=+246.34% | Revisions=+0% | GrowthEPS=-21.8% | GrowthRev=-13.7%
[Analyst] Revisions Ratio: +0% (up=2, down=2)